Profession Notes

The University of Alabama at Birmingham (UAB) will run a new national network of genetics researchers who work with microarrays, financed with a $409,000 five-year grant from the National Science Foundation. Seventeen institutions will be involved in this network that coordinates research on the use of microarray technology for gene expression. Paul Allison, professor of biostatistics in the School of Public Health at UAB, and project leader, says the network is designed to bring together resear

Written byJean Mccann
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The University of Alabama at Birmingham (UAB) will run a new national network of genetics researchers who work with microarrays, financed with a $409,000 five-year grant from the National Science Foundation. Seventeen institutions will be involved in this network that coordinates research on the use of microarray technology for gene expression. Paul Allison, professor of biostatistics in the School of Public Health at UAB, and project leader, says the network is designed to bring together researchers from different institutions and disciplines. "There are many questions remaining about how to use the technology and how to interpret the data," says Allison. For that reason, a wide variety of disciplines will be involved, including computer science, mathematics, statistics, bioinformatics, and measurement theory, as well as microarray technology itself. "Despite the growing number of published studies involving microarray technology, experts are still struggling to address issues relative to the reliability and validity of measurements made using the technology," Allison says. "The result is that the research literature may not always be up to the highest methodological standards." The two primary activities of the network will be an annual retreat for network scientists and others, to foster the open exchange of information, and a visiting scholars program. The first retreat is scheduled for this September in New Paltz, New York. In addition, the network will launch a website to support efforts of network scientists who are developing and using new methodologies and demonstrating their use though published papers, which is primarily how the information will be disseminated among the scientific community, according to Allison.
--Jean McCann

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies